Reuters: Health
Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial.
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
Reuters: Health
Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial.
Reuters: Health
Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment